Has a friend recently forwarded you a message? It goes something like: glucosamine—a supplement many people take regularly—has been “called out” by a new study for possibly being linked to dementia.

Before you rush to put the bottles at home away, let’s think. The biggest risk with news like this is reading only the headline, not the content. Today, let’s sit down and carefully sort this out: who did the study, who it is about, what the conclusion actually is, and most importantly—how ordinary people like us should view it.

1. First, the background: who did it and where it was published

The study was conducted by a team at the University of Florida in the United States and published in Nature Metabolism on June 9, 2026. The first author is Tara R. Hawkinson, and the senior author is Ramon C. Sun.

In short, this is a legitimate peer-reviewed paper, not a rumor made up online. But “having a source” does not mean the conclusion is scary—what matters is what it studied and how.

2. It studied people “already diagnosed”

This is precisely the point many people who forward the message skip over.

The study subjects were patients already diagnosed with mild cognitive impairment (MCI) or Alzheimer’s disease and related dementias (ADRD)—that is, people who already have cognitive impairment. For cognitively healthy populations, both the paper and the authors explicitly state that this harmful signal was not seen. In experiments, healthy normal mice given glucosamine also showed no related changes.

In other words, the study does not address “what happens when healthy people take a bit of glucosamine”; it addresses “what was observed in people already diagnosed.” The two are entirely different and must not be conflated.

3. It is an “observational” study

The population-level evidence comes from a retrospective analysis of electronic health records—an observational study, not a controlled trial in which people are randomly divided into two groups, one taking the supplement and one not. The paper also includes animal experiments on transgenic Alzheimer’s disease mice and mechanistic analyses of human brain autopsy tissue to explore possible mechanisms.

The hallmark of observational studies is that they can find that “two things often occur together,” but it is difficult to directly determine “which one causes which.” The authors themselves emphasize that the study can only show an association, not prove causation, and that randomized clinical trials are needed for further verification.

4. Beyond the numbers, there are these caveats

The paper mentions a relative change in risk, but that figure comes with many caveats: it is an observational result that may involve various confounding factors; the authors also note that the doses, brands, and durations of use among supplement takers are unknown, so the conclusion should be viewed cautiously. Whether findings are consistent across different studies still awaits more data.

So turning a heavily qualified figure from the paper into “taking glucosamine will give you dementia” is clearly overinterpreting.

For the length of this article, rather than agonizing over that figure, remember the sentence below.

5. Three points not to misread—keep them in mind

First, association is not causation. The study suggests an “association,” not that “glucosamine causes cognitive problems.”

Second, the conclusion applies only to already-diagnosed populations. Cognitively healthy people, pregnant women, and adolescents are all outside the scope of this study—don’t arbitrarily apply the conclusion to yourself or your family.

Third, friends currently taking glucosamine don’t need to stop on their own because of this news. If you feel uneasy, the safest approach is to consult a doctor with your own situation and let the doctor judge based on your actual condition.

6. What is glucosamine actually for?

To be frank, glucosamine (aminoglucose) is most commonly used for joint health and osteoarthritis. In China, it can be used both as an ingredient in health foods and as an over-the-counter approved preparation, with the drug indication stated as “primary and secondary osteoarthritis.”

Neither has an approved claim of “preventing or treating Alzheimer’s disease.” In other words, it was never meant to manage memory and cognition.

7. Seek medical attention promptly in these situations

If an elderly family member shows noticeably declining memory, trouble remembering what was just said, a worsening sense of direction, or personality changes, don’t hunt for “folk remedies” online and don’t assume the worst—go to a hospital memory clinic or neurology department as early as possible and let a professional doctor assess the situation. Early detection and early assessment put the initiative back in your hands.

In closing

A new study is worth attention, but not panic. Reading it in full and understanding “who it is about and how it was done” is far more useful than forwarding a scary headline.

Do you know anyone currently taking glucosamine? About news like this where “a study calls out a supplement again,” what do you most want to clarify? Feel free to share in the comments.

This article is health education and does not constitute medical or therapeutic advice. Whether to take or stop any supplement or medication, please follow your doctor’s instructions; consult a professional physician for individual circumstances.